Back to today’s briefing

Story perspectives

Breast Cancer Survivor Advocates for Research and Treatment Advances

10/6/2025

50 4 Full Breakdown

Summary

Story summary

Jennie Smythe, a breast cancer survivor, calls for patient representation in research and policy to empower communities.
Penn Medicine targets dormant "sleeper" cells, reporting about 80% elimination.
Exercise raises myokines in survivors and correlates with a 20-30% reduction in cancer cell growth.
Food and Drug Administration (FDA) is reviewing a new treatment combination for HER2-positive breast cancer, potentially redefining first-line therapy.

1 of 1

Story summary

Jennie Smythe, a breast cancer survivor, calls for patient representation in research and policy to empower communities.
Penn Medicine targets dormant "sleeper" cells, reporting about 80% elimination.
Exercise raises myokines in survivors and correlates with a 20-30% reduction in cancer cell growth.
Food and Drug Administration (FDA) is reviewing a new treatment combination for HER2-positive breast cancer, potentially redefining first-line therapy.